- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 401/14 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Patent holdings for IPC class C07D 401/14
Total number of patents in this class: 19129
10-year publication summary
|
1070
|
1072
|
1090
|
1222
|
1240
|
1246
|
1247
|
1474
|
1394
|
1229
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4826 |
449 |
| Novartis AG | 10612 |
351 |
| Boehringer Ingelheim International GmbH | 4636 |
344 |
| Merck Sharp & Dohme LLC | 3732 |
282 |
| Gilead Sciences, Inc. | 2106 |
274 |
| F. Hoffmann-La Roche AG | 7937 |
240 |
| Janssen Pharmaceutica N.V. | 3358 |
235 |
| Takeda Pharmaceutical Company Limited | 2721 |
226 |
| Merck Patent GmbH | 5752 |
207 |
| Pfizer Inc. | 3401 |
198 |
| Amgen Inc. | 4256 |
179 |
| Dana-Farber Cancer Institute, Inc. | 2626 |
174 |
| AstraZeneca AB | 2857 |
160 |
| Hoffmann-La Roche Inc. | 3546 |
155 |
| Genentech, Inc. | 4016 |
150 |
| Vertex Pharmaceuticals Incorporated | 1630 |
134 |
| Rigel Pharmaceuticals, Inc. | 530 |
125 |
| Syngenta Crop Protection AG | 6259 |
117 |
| LG Chem, Ltd. | 17706 |
110 |
| Celgene Corporation | 1403 |
101 |
| Other owners | 14918 |